<?xml version='1.0' encoding='utf-8'?>
<document id="24431005"><sentence text="Drug-drug interaction and doping, part 1: an in vitro study on the effect of non-prohibited drugs on the phase I metabolic profile of toremifene."><entity charOffset="134-144" id="DDI-PubMed.24431005.s1.e0" text="toremifene" /></sentence><sentence text="The present study was designed to provide preliminary information on the potential impact of metabolic drug-drug interaction on the effectiveness of doping control strategies currently followed by the anti-doping laboratories to detect the intake of banned agents" /><sentence text=" In vitro assays based on the use of human liver microsomes and recombinant CYP isoforms were designed and performed to characterize the phase I metabolic profile of the prohibited agent toremifene, selected as a prototype drug of the class of selective oestrogen receptor modulators, both in the absence and in the presence of medicaments (fluconazole, ketoconazole, itraconazole, miconazole, cimetidine, ranitidine, fluoxetine, paroxetine, nefazodone) not included in the World Anti-Doping Agency list of prohibited substances and methods and frequently administered to athletes"><entity charOffset="187-197" id="DDI-PubMed.24431005.s3.e0" text="toremifene" /><entity charOffset="254-263" id="DDI-PubMed.24431005.s3.e1" text="oestrogen" /><entity charOffset="341-352" id="DDI-PubMed.24431005.s3.e2" text="fluconazole" /><entity charOffset="354-366" id="DDI-PubMed.24431005.s3.e3" text="ketoconazole" /><entity charOffset="368-380" id="DDI-PubMed.24431005.s3.e4" text="itraconazole" /><entity charOffset="382-392" id="DDI-PubMed.24431005.s3.e5" text="miconazole" /><entity charOffset="394-404" id="DDI-PubMed.24431005.s3.e6" text="cimetidine" /><entity charOffset="406-416" id="DDI-PubMed.24431005.s3.e7" text="ranitidine" /><entity charOffset="418-428" id="DDI-PubMed.24431005.s3.e8" text="fluoxetine" /><entity charOffset="430-440" id="DDI-PubMed.24431005.s3.e9" text="paroxetine" /><entity charOffset="442-452" id="DDI-PubMed.24431005.s3.e10" text="nefazodone" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e0" e2="DDI-PubMed.24431005.s3.e0" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e0" e2="DDI-PubMed.24431005.s3.e1" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e0" e2="DDI-PubMed.24431005.s3.e2" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e0" e2="DDI-PubMed.24431005.s3.e3" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e0" e2="DDI-PubMed.24431005.s3.e4" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e0" e2="DDI-PubMed.24431005.s3.e5" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e0" e2="DDI-PubMed.24431005.s3.e6" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e0" e2="DDI-PubMed.24431005.s3.e7" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e0" e2="DDI-PubMed.24431005.s3.e8" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e0" e2="DDI-PubMed.24431005.s3.e9" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e0" e2="DDI-PubMed.24431005.s3.e10" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e1" e2="DDI-PubMed.24431005.s3.e1" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e1" e2="DDI-PubMed.24431005.s3.e2" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e1" e2="DDI-PubMed.24431005.s3.e3" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e1" e2="DDI-PubMed.24431005.s3.e4" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e1" e2="DDI-PubMed.24431005.s3.e5" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e1" e2="DDI-PubMed.24431005.s3.e6" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e1" e2="DDI-PubMed.24431005.s3.e7" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e1" e2="DDI-PubMed.24431005.s3.e8" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e1" e2="DDI-PubMed.24431005.s3.e9" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e1" e2="DDI-PubMed.24431005.s3.e10" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e2" e2="DDI-PubMed.24431005.s3.e2" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e2" e2="DDI-PubMed.24431005.s3.e3" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e2" e2="DDI-PubMed.24431005.s3.e4" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e2" e2="DDI-PubMed.24431005.s3.e5" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e2" e2="DDI-PubMed.24431005.s3.e6" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e2" e2="DDI-PubMed.24431005.s3.e7" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e2" e2="DDI-PubMed.24431005.s3.e8" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e2" e2="DDI-PubMed.24431005.s3.e9" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e2" e2="DDI-PubMed.24431005.s3.e10" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e3" e2="DDI-PubMed.24431005.s3.e3" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e3" e2="DDI-PubMed.24431005.s3.e4" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e3" e2="DDI-PubMed.24431005.s3.e5" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e3" e2="DDI-PubMed.24431005.s3.e6" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e3" e2="DDI-PubMed.24431005.s3.e7" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e3" e2="DDI-PubMed.24431005.s3.e8" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e3" e2="DDI-PubMed.24431005.s3.e9" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e3" e2="DDI-PubMed.24431005.s3.e10" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e4" e2="DDI-PubMed.24431005.s3.e4" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e4" e2="DDI-PubMed.24431005.s3.e5" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e4" e2="DDI-PubMed.24431005.s3.e6" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e4" e2="DDI-PubMed.24431005.s3.e7" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e4" e2="DDI-PubMed.24431005.s3.e8" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e4" e2="DDI-PubMed.24431005.s3.e9" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e4" e2="DDI-PubMed.24431005.s3.e10" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e5" e2="DDI-PubMed.24431005.s3.e5" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e5" e2="DDI-PubMed.24431005.s3.e6" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e5" e2="DDI-PubMed.24431005.s3.e7" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e5" e2="DDI-PubMed.24431005.s3.e8" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e5" e2="DDI-PubMed.24431005.s3.e9" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e5" e2="DDI-PubMed.24431005.s3.e10" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e6" e2="DDI-PubMed.24431005.s3.e6" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e6" e2="DDI-PubMed.24431005.s3.e7" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e6" e2="DDI-PubMed.24431005.s3.e8" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e6" e2="DDI-PubMed.24431005.s3.e9" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e6" e2="DDI-PubMed.24431005.s3.e10" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e7" e2="DDI-PubMed.24431005.s3.e7" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e7" e2="DDI-PubMed.24431005.s3.e8" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e7" e2="DDI-PubMed.24431005.s3.e9" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e7" e2="DDI-PubMed.24431005.s3.e10" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e8" e2="DDI-PubMed.24431005.s3.e8" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e8" e2="DDI-PubMed.24431005.s3.e9" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e8" e2="DDI-PubMed.24431005.s3.e10" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e9" e2="DDI-PubMed.24431005.s3.e9" /><pair ddi="false" e1="DDI-PubMed.24431005.s3.e9" e2="DDI-PubMed.24431005.s3.e10" /></sentence><sentence text=" The results show that the in vitro model developed in this study was adequate to simulate the in vivo metabolism of toremifene, confirming the results obtained in previous studies"><entity charOffset="117-127" id="DDI-PubMed.24431005.s4.e0" text="toremifene" /></sentence><sentence text=" Furthermore, our data also show that ketoconazole, itraconazole, miconazole and nefazodone cause a marked modification in the production of the metabolic products (i"><entity charOffset="38-50" id="DDI-PubMed.24431005.s5.e0" text="ketoconazole" /><entity charOffset="52-64" id="DDI-PubMed.24431005.s5.e1" text="itraconazole" /><entity charOffset="66-76" id="DDI-PubMed.24431005.s5.e2" text="miconazole" /><entity charOffset="81-91" id="DDI-PubMed.24431005.s5.e3" text="nefazodone" /><pair ddi="false" e1="DDI-PubMed.24431005.s5.e0" e2="DDI-PubMed.24431005.s5.e0" /><pair ddi="false" e1="DDI-PubMed.24431005.s5.e0" e2="DDI-PubMed.24431005.s5.e1" /><pair ddi="false" e1="DDI-PubMed.24431005.s5.e0" e2="DDI-PubMed.24431005.s5.e2" /><pair ddi="false" e1="DDI-PubMed.24431005.s5.e0" e2="DDI-PubMed.24431005.s5.e3" /><pair ddi="false" e1="DDI-PubMed.24431005.s5.e1" e2="DDI-PubMed.24431005.s5.e1" /><pair ddi="false" e1="DDI-PubMed.24431005.s5.e1" e2="DDI-PubMed.24431005.s5.e2" /><pair ddi="false" e1="DDI-PubMed.24431005.s5.e1" e2="DDI-PubMed.24431005.s5.e3" /><pair ddi="false" e1="DDI-PubMed.24431005.s5.e2" e2="DDI-PubMed.24431005.s5.e2" /><pair ddi="false" e1="DDI-PubMed.24431005.s5.e2" e2="DDI-PubMed.24431005.s5.e3" /></sentence><sentence text="e" /><sentence text=" hydroxylated and carboxylated metabolites) normally selected by the anti-doping laboratories as target analytes to detect toremifene intake; moderate variations were registered in the presence of fluconazole, paroxetine and fluoxetine; while no significant modifications were measured in the presence of ranitidine and cimetidine"><entity charOffset="123-133" id="DDI-PubMed.24431005.s7.e0" text="toremifene" /><entity charOffset="197-208" id="DDI-PubMed.24431005.s7.e1" text="fluconazole" /><entity charOffset="210-220" id="DDI-PubMed.24431005.s7.e2" text="paroxetine" /><entity charOffset="225-235" id="DDI-PubMed.24431005.s7.e3" text="fluoxetine" /><entity charOffset="305-315" id="DDI-PubMed.24431005.s7.e4" text="ranitidine" /><entity charOffset="320-330" id="DDI-PubMed.24431005.s7.e5" text="cimetidine" /><pair ddi="false" e1="DDI-PubMed.24431005.s7.e0" e2="DDI-PubMed.24431005.s7.e0" /><pair ddi="false" e1="DDI-PubMed.24431005.s7.e0" e2="DDI-PubMed.24431005.s7.e1" /><pair ddi="false" e1="DDI-PubMed.24431005.s7.e0" e2="DDI-PubMed.24431005.s7.e2" /><pair ddi="false" e1="DDI-PubMed.24431005.s7.e0" e2="DDI-PubMed.24431005.s7.e3" /><pair ddi="false" e1="DDI-PubMed.24431005.s7.e0" e2="DDI-PubMed.24431005.s7.e4" /><pair ddi="false" e1="DDI-PubMed.24431005.s7.e0" e2="DDI-PubMed.24431005.s7.e5" /><pair ddi="false" e1="DDI-PubMed.24431005.s7.e1" e2="DDI-PubMed.24431005.s7.e1" /><pair ddi="false" e1="DDI-PubMed.24431005.s7.e1" e2="DDI-PubMed.24431005.s7.e2" /><pair ddi="false" e1="DDI-PubMed.24431005.s7.e1" e2="DDI-PubMed.24431005.s7.e3" /><pair ddi="false" e1="DDI-PubMed.24431005.s7.e1" e2="DDI-PubMed.24431005.s7.e4" /><pair ddi="false" e1="DDI-PubMed.24431005.s7.e1" e2="DDI-PubMed.24431005.s7.e5" /><pair ddi="false" e1="DDI-PubMed.24431005.s7.e2" e2="DDI-PubMed.24431005.s7.e2" /><pair ddi="false" e1="DDI-PubMed.24431005.s7.e2" e2="DDI-PubMed.24431005.s7.e3" /><pair ddi="false" e1="DDI-PubMed.24431005.s7.e2" e2="DDI-PubMed.24431005.s7.e4" /><pair ddi="false" e1="DDI-PubMed.24431005.s7.e2" e2="DDI-PubMed.24431005.s7.e5" /><pair ddi="false" e1="DDI-PubMed.24431005.s7.e3" e2="DDI-PubMed.24431005.s7.e3" /><pair ddi="false" e1="DDI-PubMed.24431005.s7.e3" e2="DDI-PubMed.24431005.s7.e4" /><pair ddi="false" e1="DDI-PubMed.24431005.s7.e3" e2="DDI-PubMed.24431005.s7.e5" /><pair ddi="false" e1="DDI-PubMed.24431005.s7.e4" e2="DDI-PubMed.24431005.s7.e4" /><pair ddi="false" e1="DDI-PubMed.24431005.s7.e4" e2="DDI-PubMed.24431005.s7.e5" /></sentence><sentence text=" This evidence imposes that the potential effect of drug-drug interactions is duly taken into account in anti-doping analysis, also for a broader significance of the analytical results" /><sentence text="" /></document>